
open access
메뉴
E-ISSN : 2671-6771
Short stature is a common reason for referral to pediatric endocrinologists, yet its underlying cause often remains unidentified despite comprehensive clinical and biochemical evaluation. Recent advances in molecular genetic testing have revealed that a substantial proportion of children previously classified as having idiopathic short stature harbor pathogenic genetic variants. This review summarizes current genetic approaches to short stature and highlights major genes involved in growth plate regulation and the growth hormone–insulin-like growth factor 1 axis. Variants in genes such as SHOX, ACAN, NPR2, NPPC, IHH, and FGFR3 can disrupt growth plate chondrogenesis, whereas defects in GH1, GHR, IGF1, and IGF1R affect the GH–IGF-1 pathway. In addition, mild syndromic disorders, including those associated with PTPN11 variants, may present primarily as short stature. Phenotypic features, including body disproportion, bone age, biochemical findings, and family history, can provide important clues for selecting appropriate genetic tests. However, because many affected children lack distinctive clinical features, multigene panels and exome sequencing are increasingly important diagnostic tools. Establishing a molecular diagnosis may reduce unnecessary investigations, improve prognostic assessment, guide treatment decisions, and enable more individualized management. Genetic testing is therefore likely to become an increasingly integral component of the evaluation of children with unexplained short stature.